Li Ou. “TNFRSF1B-DRIVEN MYELOID PLASTICITY CONSTITUTES A CLINICALLY TRACTABLE IMMUNOSUPPRESSIVE AXIS ACROSS HUMAN CANCERS”. LIFE: International Journal of Health and Life-Sciences, Nov. 2025, pp. 65-66, doi:10.20319/icrlsh.2025.6566.